Literature DB >> 29637311

Institutional Pathways to Improve Care of Patients with Elevated Blood Pressure in the Emergency Department.

Aaron M Brody1, Joseph Miller2,3, Rimma Polevoy3, Asaad Nakhle3, Phillip D Levy4.   

Abstract

PURPOSE OF REVIEW: Hypertension (HTN) is the most prevalent cardiovascular disease and poses a major population level risk to long-term health outcomes. Despite this critical importance, and the widespread availability of effective and affordable medications, blood pressure (BP) remains uncontrolled in up to 50% of the diagnosed patients. This problem is exacerbated in communities with limited access to primary care, who often utilize hospital emergency departments (EDs) as their primary healthcare resource. Despite the ubiquity of patients presenting to EDs with severely elevated BP, a unified, evidence-based approach is not yet widely implemented, and both under- and overtreatment are common. The purpose of this review is to describe an approach towards institutional policy regarding asymptomatic HTN, in which we will translate the accepted principles of appropriate outpatient BP management to ED and inpatient settings. RECENT
FINDINGS: Results from the recent SPRINT trial, and the subsequent publication of the American Heart Association updated guidelines for the treatment of HTN, significantly lower both the diagnostic threshold and the treatment goals for hypertensive patients. This change will drastically increase the proportion of patients presenting to EDs with newly diagnosed and uncontrolled HTN. Several recent studies emphasize the safety in outpatient management of patients with severely elevated BP in the absence of acute end-organ damage and, conversely, the long- and intermediate-term risk associated with these patients. System-based approaches, particularly those led by non-physicians, have shown the greatest promise in reducing population level uncontrolled HTN. Evidence-based approaches, such as those described in emergency medicine and cardiology society guidelines, can guide appropriate management of ED and inpatient BP elevations. Translating these patient oriented guidelines into institutional policy, and maintaining provider adherence, is a challenge across healthcare institutions. We present here several examples of successful policies developed and implemented by the authors. While brief inpatient and ED encounters cannot replace long-term outpatient care, they have the potential to serve as a crucial inlet to health care and an opportunity to optimize care.

Entities:  

Keywords:  Antihypertensive therapy; Emergency department; Hypertension; Hypertensive emergency; Hypertensive urgency; Institutional policy; Severely elevated blood pressure

Mesh:

Year:  2018        PMID: 29637311     DOI: 10.1007/s11906-018-0831-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  40 in total

1.  Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension.

Authors:  James J Mahn; Elizabeth Dubey; Aaron Brody; Robert Welch; Robert Zalenski; John M Flack; Brian Ference; Phillip D Levy
Journal:  Acad Emerg Med       Date:  2014-09       Impact factor: 3.451

2.  Appropriate Management of Asymptomatic Hypertension.

Authors:  Candace D McNaughton; Aaron Brody; Phillip D Levy
Journal:  JAMA Intern Med       Date:  2016-11-01       Impact factor: 21.873

3.  Elevated blood pressure in the emergency department: lack of adherence to clinical practice guidelines.

Authors:  Srikar Adhikari; Ross Mathiasen; Lina Lander
Journal:  Blood Press Monit       Date:  2016-02       Impact factor: 1.444

4.  Barriers to screening and intervention for ED patients at risk for undiagnosed or uncontrolled hypertension.

Authors:  Paula Tanabe; David M Cline; John J Cienki; Darcy Egging; Jill F Lehrmann; Brigitte M Baumann
Journal:  J Emerg Nurs       Date:  2010-03-04       Impact factor: 1.836

5.  Subclinical hypertensive heart disease in black patients with elevated blood pressure in an inner-city emergency department.

Authors:  Phillip Levy; Hong Ye; Scott Compton; Robert Zalenski; Timothy Byrnes; John M Flack; Robert Welch
Journal:  Ann Emerg Med       Date:  2012-05-31       Impact factor: 5.721

6.  Provider self-report and practice: reassessment and referral of emergency department patients with elevated blood pressure.

Authors:  Brigitte M Baumann; David M Cline; John J Cienki; Darcy Egging; Jill F Lehrmann; Paula Tanabe
Journal:  Am J Hypertens       Date:  2009-03-05       Impact factor: 2.689

7.  Improved blood pressure control associated with a large-scale hypertension program.

Authors:  Marc G Jaffe; Grace A Lee; Joseph D Young; Stephen Sidney; Alan S Go
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

8.  Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.

Authors:  Wendy A Gattis; Christopher M O'Connor; Dianne S Gallup; Vic Hasselblad; Mihai Gheorghiade
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

9.  Trends in the Incidence of Hypertensive Emergencies in US Emergency Departments From 2006 to 2013.

Authors:  Alexander T Janke; Candace D McNaughton; Aaron M Brody; Robert D Welch; Phillip D Levy
Journal:  J Am Heart Assoc       Date:  2016-12-05       Impact factor: 5.501

10.  A Mobile Phone-Based Health Coaching Intervention for Weight Loss and Blood Pressure Reduction in a National Payer Population: A Retrospective Study.

Authors:  Alice Yuqing Mao; Connie Chen; Candy Magana; Karla Caballero Barajas; J Nwando Olayiwola
Journal:  JMIR Mhealth Uhealth       Date:  2017-06-08       Impact factor: 4.773

View more
  1 in total

1.  Unmet challenges in treating hypertension in patients with borderline personality disorder: A systematic review.

Authors:  Saara M Roininen; Marcus Cheetham; Beatrice U Mueller; Edouard Battegay
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.